Neos Therapeutics, Inc. — Form D/A

Neos Therapeutics, Inc. of GRAND PRAIRIE, TX, a company, filed a Form D amendment with the SEC on 2015-02-20. The offering totals $20.6M, of which $20.6M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Bryant FongDirectorGrand Prairie, TX
Vipin GargDirectorGrand Prairie, TX
Alan HellerDirectorGrand Prairie, TX
Ralph IannelliDirectorGrand Prairie, TX
Greg RobitailleDirectorGrand Prairie, TX
Edward SchnipperDirectorGrand Prairie, TX
Margaret CabanoExecutive OfficerGrand Prairie, TX
Richard EisenstadtExecutive OfficerGrand Prairie, TX
Dorothy EngelkingExecutive OfficerGrand Prairie, TX
Arlen EwartExecutive OfficerGrand Prairie, TX
Vipin GargExecutive OfficerGrand Prairie, TX
Steven LutzExecutive OfficerGrand Prairie, TX
Russ McMahenExecutive OfficerGrand Prairie, TX
Asif MughalExecutive OfficerGrand Prairie, TX
Carolyn SikesExecutive OfficerGrand Prairie, TX
Stacie SwitzerExecutive OfficerGrand Prairie, TX
Mark TenglerExecutive OfficerGrand Prairie, TX
Victor MillerExecutive OfficerPalo Alto, CA
JOHN CLARKExecutive OfficerLexington, TN
Karl HandelsmanDirectorGrand Prairie, TX
Bryan HillExecutive OfficerGrand Prairie, TX
Ellen HoffingExecutive OfficerGrand Prairie, TX
Margaret LokashExecutive OfficerGrand Prairie, TX
Dorothy FrankExecutive OfficerGrand Prairie, TX
Mark Van AusdalExecutive OfficerGrand Prairie, TX

Other filings by this issuer (10)

FiledFormOfferingSold
2015-01-07D$15.0M$8.0M
2014-04-09D$2.5M$2.5M
2014-03-04D/A$15.5M$15.5M
2014-01-02D$15.0M$8.1M
2012-07-16D$30.0M$18.3M
2011-06-09D$20.0M$13.6M
2009-11-23D/A$50.0M$24.2M
2009-10-07D/A$40.0M$19.2M
2009-10-07D/A$40.0M$19.1M
2009-07-02D$40.0M$14.6M

More